Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

IPHA

Innate Pharma SA

CIK 0001598599 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$2.26
↑ 0.17 (8.13%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Technicals; Risks: Ownership; Excluded: Fundamentals, Options (no data)

Key stats

Market Cap
$212.22M
P/E Ratio
Not covered
EPS
-0.55
Dividend Yield
Not covered
52W Position
71%
Beta
1.52

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
Not covered
P/S
Not covered
EV/Revenue
Not covered
ROE
Not covered
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 71%
$1.17$2.71

Latest Financials

2025-12-31 FY
Revenue
$9.01M
Net Income
-$49.18M
Total Assets
$62.72M
Free Cash Flow
-$52.90M

Recent news